Abstract:The direct impact and sequelae of infections in children and adults result in significant morbidity and mortality especially when they involve the central (CNS) or peripheral nervous system (PNS). The historical understanding of the pathophysiology has been mostly focused on the direct impact of the various pathogens through neural tissue invasion. However, with the better understanding of neuroimmunology, there is a rapidly growing realization of the contribution of the innate and adaptive host immune responses in the pathogenesis of many CNS and PNS diseases. The balance between the protective and pathologic sequelae of immunity is fragile and can easily be tipped towards harm for the host. The matter of immune privilege and surveillance of the CNS/PNS compartments and the role of the blood-brain barrier (BBB) and blood nerve barrier (BNB) makes this even more complex. Our understanding of the pathogenesis of many post-infectious manifestations of various microbial agents remains elusive, especially in the diverse African setting. Our exploration and better understanding of the neuroimmunology of some of the infectious diseases that we encounter in the continent will go a long way into helping us to improve their management and therefore lessen the burden. Africa is diverse and uniquely poised because of the mix of the classic, well described, autoimmune disease entities and the specifically "tropical" conditions. This review explores the current understanding of some of the para- and post-infectious autoimmune manifestations of CNS and PNS diseases in the African context. We highlight the clinical presentations, diagnosis and treatment of these neurological disorders and underscore the knowledge gaps and perspectives for future research using disease models of conditions that we see in the continent, some of which are not uniquely African and, where relevant, include discussion of the proposed mechanisms underlying pathogen-induced autoimmunity. This review covers the following conditions as models and highlight those in which a relationship with COVID-19 infection has been reported: a) Acute Necrotizing Encephalopathy; b) Measles-associated encephalopathies; c) Human Immunodeficiency Virus (HIV) neuroimmune disorders, and particularly the difficulties associated with classical post-infectious autoimmune disorders such as the Guillain-Barré syndrome in the context of HIV and other infections. Finally, we describe NMDA-R encephalitis, which can be post-HSV encephalitis, summarise other antibody-mediated CNS diseases and describe myasthenia gravis as the classic antibody-mediated disease but with special features in Africa.

Neuroimmune disorders of the central nervous system in children in the molecular era

Precise diagnosis and treatment of pediatric central nervous system immune-related disease under molecular era

CNS and CNS Diseases in Relation to Their Immune System

Origins and immunopathogenesis of autoimmune central nervous system disorders

Meningeal Immunity and Neurological Diseases: New Approaches, New Insights

Neuropsychiatric disorders: An immunological perspective

Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders

Species differences in immune‐mediated CNS tissue injury and repair: A (neuro)inflammatory topic

Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective

Neuroimmune mechanisms in health and disease: 2. Disease

Implications of Inflammatory Processes on a Developing Central Nervous System in Childhood-Onset Systemic Lupus Erythematosus

Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?

Immune-mediated diseases involving central and peripheral nervous systems

The immunology underlying CNS autoantibody diseases

Immuno-NeuroPsychiatry on the Path to Clinical Application

The Clinical Spectrum of Autoimmune-Mediated Neurological Diseases in Paediatric Population

Neurodevelopmental and Neuropsychiatric Disorders

Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions

Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis

Immunological Drivers and Potential Novel Drug Targets for Major Psychiatric, Neurodevelopmental, and Neurodegenerative Conditions

Neuroimmune interactions and their roles in neurodegenerative diseases